Association of continuous subcutaneous insulin therapy and diabetic retinopathy in type 1 diabetes: A national cohort study.

Anne S ThykjærLouise RosengaardNis AndersenJens AndresenJavad HajariSteffen HeegaardKurt HøjlundRyo KawasakiCaroline S LaugesenSören MöllerFrederik N PedersenKatja SchielkeLonny M StokholmJakob Grauslund

Published in: Journal of diabetes and its complications (2024)

Our findings indicate that CSII treatment does not confer a significant difference in the overall short- and long-term risk of DR worsening or ocular intervention compared to MDI treatment. These results provide insights into the DR outcomes of CSII treatment in individuals with type 1 diabetes.

Keyphrases

type diabetes
diabetic retinopathy
randomized controlled trial
stem cells
glycemic control
insulin resistance
combination therapy
quality improvement